Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 17Myelodysplastic Syndromes 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Hematologic Neoplasms 9Myeloproliferative Disorders 8Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 7Lymphoma, Non-Hodgkin 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Lymphoma 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Prolymphocytic 4Leukemia, Myelomonocytic, Chronic 4Skin Neoplasms 3Sarcoma 3Rhabdomyosarcoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Biphenotypic, Acute 3Leukemia 3Bronchiolitis Obliterans Syndrome 3

Interventions

ruxolitinib 3venetoclax 2fludarabine phosphate 2duvelisib 2thymoglobulin 1romidepsin 1itacitinib 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Lisaftoclax 1Depsipeptides 1Cyclosporins 1Cyclosporine 1Cladribine 1Busulfan 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Prolymphocytic, T-Cell × Sirolimus × 1 year × Clear all
NCT01231412 2026-04-30

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 3 Completed
174 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡